Claybrook Capital, LLC Novartis Ag Transaction History

Claybrook Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $1.26 Million - $1.47 Million	-15,463 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$85.24 - $94.15 $1.32 Million - $1.46 Million	15,463 New	15,463 $1.41 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $5,423 - $6,202	-72 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $5,303 - $5,905	72 New	72 $5,000
Q1 2018 May 11, 2018	SELL	$70.39 - $84.15 $19,357 - $23,141	-275 Closed	0 $0
Q4 2017 May 08, 2018	BUY	$72.33 - $77.64 $19,890 - $21,351	275	275 $23,000

1,423

130M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Claybrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Claybrook Capital, LLC with notifications on news.